US FDA, NCI Collaboration Deepens To Include Clinical Trial Innovation ‘Think Tank’

Former NCI Director Monica Bertagnolli, who now is head of the NIH, said FDA, NCI and National Clinical Trials Network officials are working on potential clinical trial system innovations.

Monica Bertagnolli (center) and Robert Califf (right) at the Friends of Cancer Research Annual Meeting
Friends of Cancer Research President and CEO Jeff Allen (left) moderates a discussion with NIH Director Monica Bertagnolli (center) and FDA Commissioner Robert Califf (right) during the FOCR Annual Meeting. • Source: Screenshot of internet broadcast

The US Food and Drug Administration and National Cancer Institute are collaborating to incubate clinical trial system improvements in an expansion of the partnership between the agencies.

Monica Bertagnolli, who had been NCI director before recently being confirmed as National Institutes of Health director, said the “think tank” grew out of an idea discussed last year and now includes NCI, the

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Clinical Trials

More from R&D